Endovia Health Sciences, Inc. (EDVA)

NYSEAMERICAN: EDVA · USD

$0.18

+0.00 (+2.6%)· Recorded snapshot

Market cap	1.2M
Revenue (ttm)	32.1K
Net income (ttm)	-18.8M
EPS (ttm)	-$13.6
Shares out	6.4M
Volume	1,014,752.219
Beta	-1.11

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 32.1K
Net income (ttm): -18.8M
EPS (ttm): -$13.6
Market cap: 1.2M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-04 14:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC-503.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All EDVA indicators

Market & fundamental data

Available fields

189

Groups with data

Currency

USD

Showing 189 of 189 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001553788
Company name	Endovia Health Sciences, Inc.
Country	United States
Country code	US
CUSIP number	84862C401
Earnings date	2026-11-28
Earnings time	bmo
Employees	2
Employees change	-19
Employees growth	-90.48%
Enterprise value	$7.3M
Exchange	NYSEAMERICAN
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-08-30
Fiscal year end	December
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US84862C4015
Last earnings date	2026-08-19
Last refreshed	2026-11-04
Last stock split date	2026-07-27
Last stock split type	Reverse
Market cap	$1.2M
Market cap category	Nano-Cap
Next earnings date	2026-11-28
Options	No
Price	$0.18
Price currency	USD
Sector	Healthcare
Stock price date	2026-11-03
Symbol	EDVA
U.S. state	Florida
Website	https://EndoviaSciences.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-7,577.23%
EV/Sales	227.34x
FCF / EV yield	-74.11%
FCF yield	-469.74%
Forward EV/Sales	0.75x
Forward P/S	0.12x
P/S ratio	35.87x
Sector forward P/E	23.32x
Sector P/E	49.47x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Operating margin	-45,159.07%
Pretax margin	-52,525.52%
Profit per employee	$-9.4M
Revenue per employee	$16,045
ROA	-77.7%
ROA (5Y)	-176.09%
ROCE	92.02%
ROIC	-503.14%
SBC / revenue	29,809.46%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	3
EPS growth years	5
Net income growth quarters	3
Net income growth years	0
Revenue growth	-90.88%
Revenue growth 3Y	-88.42%
Revenue growth 5Y	-66.13%
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Depreciation and amortization	$9,284
EBIT	$-14.5M
EBITDA	$-14.5M
EPS	$-13.60
FCF per share	$-0.84
Financing cash flow	$5.9M
Free cash flow	$-5.4M
Free cash flow minus SBC	$-15M
Gross profit	$-453,935
Investing cash flow	$-204,553
Net borrowing	$2.3M
Net cash flow	$227,046
Net income	$-18.8M
Operating cash flow minus SBC	$-15M
Operating income	$-14.5M
Revenue	$32,090
Stock-based compensation	$9.6M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-305.06
Book value per share	$-3.82
Interest coverage	-5.58
Long-term assets	$175,925
Long-term liabilities	$0
Net cash (debt)	$-6.1M
Net cash / market cap	-533.8%
Piotroski F-Score	1
Shareholders' equity	$-15.7M
Tangible book value	$-15.7M
Tangible book value per share	$-3.82
Total assets	$1.1M
Total cash	$242,702
Total debt	$6.4M
Total liabilities	$16.8M
WACC	26.96%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0
Current assets	$900,407
Current liabilities	$16.8M
Current ratio	0.05
Inventory turnover	1.07
Net working capital	$-9.8M
Quick ratio	0.02
Working capital	$-15.9M
Working capital turnover	-0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-236.95%
Dividend yield	0%
Shareholder yield	-236.95%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$0.66
1D price change	2.63%
1M price change	12.61%
1M total return	12.61%
1W price change	8.72%
1W total return	8.72%
1Y price change	-97.25%
1Y return CAGR	-97.25%
1Y total return	-97.25%
20-day SMA	$0.16
200-day SMA	$1.08
3M price change	-51.49%
3M total return	-51.49%
3Y price change	-99.78%
3Y return CAGR	-87.08%
3Y total return	-99.78%
50-day SMA	$0.21
50-day SMA vs 200-day SMA	50under200
52-week high	$6.76
52-week high date	2025-12-02
52-week low	$0.13
52-week low date	2026-10-15
5Y price change	-99.95%
5Y return CAGR	-77.76%
5Y total return	-99.95%
6M price change	-81.96%
6M total return	-81.96%
After-hours change	1.34%
After-hours close	$0.18
After-hours price	$0.18
All-time high	$2,448.02
All-time high date	2020-08-26
All-time low	$0.13
All-time low date	2026-10-15
Average true range (ATR)	$0.02
Average volume	498.7K
Beta (1Y)	2.35
Beta (2Y)	1.64
Beta (5Y)	-1.11
Change from 52-week high	-97.34%
Change from 52-week low	33.56%
Change from all-time high	-99.99%
Change from all-time low	33.56%
Change from open	2.4%
Day's gap	0.23%
Dollar volume	$182,148
High price	$0.19
Low price	$0.17
Monthly RSI	39.17
Open price	$0.18
Position in 52-week range	47.74%
Premarket change	2.79%
Premarket close	$0.18
Premarket price	$0.18
Premarket volume	16.2K
Previous close	$0.17
Price vs 150-day SMA	-72.62%
Price vs 20-day SMA	14.62%
Price vs 200-day SMA	-83.33%
Price vs 50-day SMA	-13.83%
Relative volume	2.03
RSI	50.92
Sharpe ratio	-1.27
Sharpe ratio (3Y)	-0.55
Sharpe ratio (5Y)	-0.32
Sortino ratio	-2.02
Sortino ratio (3Y)	-0.9
Sortino ratio (5Y)	-0.53
Volume	1M
Weekly RSI	31.07
YTD price change	-93.5%
YTD total return	-93.5%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5.6M
Float percentage	87.44%
Shares change (QoQ)	168.36%
Shares change (YoY)	236.95%
Shares held by insiders	0.12%
Shares held by institutions	4.72%
Shares outstanding	6.4M
Short % of float	3.79%
Short % of shares	3.31%
Short ratio	0 days

Deeper analysis on EDVA

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this EDVA report

Is a complete EDVA research report available?

No complete published report is available for Endovia Health Sciences, Inc. (EDVA) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Endovia Health Sciences, Inc. (EDVA)

Price

Financial snapshot

Fair-value bridge

Latest news · EDVA

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All EDVA indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on EDVA

Frequently asked questions